India, April 2 -- AngioDynamics, Inc. (ANGO) Wednesday reported net loss of $4.41 million or $0.11 per share for the third quarter, significantly lower than $187.74 million or $4.67 per share loss in the same quarter a year ago, primarily due to goodwill impairment charges of $159.48 million in the prior-year quarter.
Third-quarter results beat analysts' view. The medical technology company also raised its full-year outlook above the Street expectations. Its shares were more than 10 percent up in pre-market.
Excluding one-time items, loss narrowed to $3.1 million or $0.08 per share, from $6.5 million or $0.16 loss per share a year ago.
Sales for the quarter declined to $72 million from $75.18 million last year. Proforma sales grew 9.2 pe...